Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Nonexclusive licensing opportunity in HCV protease inhibitor research announced by Chiron

Oct. 6, 1997

Byk Gulden presents new gastric antisecretory agents

Oct. 2, 1997

Launch announced for new ulcerative colitis Rx

Oct. 1, 1997

Intron A/ribavirin combination for HCV: preliminary phase III results

Sep. 30, 1997

Pentoxifylline demonstrates gastroprotective effects in patient study

Sep. 30, 1997

L-Arginine for liver ischemia/reperfusion injury and transplantation

Sep. 25, 1997

Colonic prokinetic agent discovered by Janssen

Sep. 25, 1997

Octreotide acetate clinical study commences for new indication

Sep. 23, 1997

Apotex launches generic ranitidine in U.S.

Sep. 16, 1997

SciClone issued European patent for use of thymosin alpha 1 for hepatitis C

Sep. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...